Literature DB >> 22406143

Ethanol infusion in the vein of Marshall facilitates mitral isthmus ablation.

José L Báez-Escudero1, Percy Francisco Morales, Amish S Dave, Christine M Sasaridis, Young-Hoon Kim, Kaoru Okishige, Miguel Valderrábano.   

Abstract

BACKGROUND: Treatment of perimitral flutter (PMF) requires bidirectional mitral isthmus (MI) block, which can be difficult with radiofrequency ablation (RFA). The vein of Marshall (VOM) is located within the MI.
OBJECTIVE: To test whether VOM ethanol infusion could help achieve MI block.
METHODS: Perimitral conduction was studied in patients undergoing ablation of atrial fibrillation. Group 1 included 50 patients with a previous atrial fibrillation ablation undergoing repeat ablation, 30 of whom had had MI ablation. Spontaneous (8 of 50) or inducible PMF (21 of 50) was confirmed by activation mapping. Group 2 included 21 patients undergoing de novo VOM ethanol infusion. The VOM was cannulated with a quadripolar catheter for pacing and with an angioplasty balloon to deliver up to four 1-mL infusions of 98% ethanol. Voltage maps were created before and after VOM ethanol infusion. Bidirectional MI block was verified by differential pacing. RFA times required to achieve it were assessed.
RESULTS: In group 1, VOM ethanol infusion acutely terminated PMF in 5 of 29 patients. RFA needed to achieve bidirectional MI block was 2.2 ± 1.6 minutes. Presence of PMF or previous MI ablation did not affect RFA times. In group 2, RFA needed to achieve bidirectional MI block was 2.0 ± 1.6 minutes (P = NS). Five patients had bidirectional MI block achieved solely by VOM ethanol infusion without RFA. In both groups, ablation after VOM ethanol infusion was required in the annular aspect of the MI. There were no acute complications.
CONCLUSION: VOM ethanol infusion is useful in the treatment of PMF and assists in reliably achieving bidirectional MI block.
Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22406143      PMCID: PMC3419362          DOI: 10.1016/j.hrthm.2012.03.008

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  32 in total

1.  Recurrent atrial arrhythmia in patients with atrial fibrillation following pulmonary vein isolation.

Authors:  Seiichiro Matsuo; Teiichi Yamane; Mika Hioki; Keiichi Ito; Shin-Ichi Tanigawa; Seigo Yamashita; Keiichi Inada; Taro Date; Michihiro Yoshimura
Journal:  J Cardiovasc Electrophysiol       Date:  2011-02-25

2.  Recurrent perimitral tachycardia using epicardial coronary sinus connection to bypass endocardial conduction block at the mitral isthmus.

Authors:  Shinsuke Miyazaki; Ashok J Shah; Michel Haïssaguerre
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-08

3.  Feasibility of catheter ablation of mitral annular flutter in patients with prior mitral valve surgery.

Authors:  Stavros Mountantonakis; David S Frankel; Mathew D Hutchinson; Sanjay Dixit; Michael Riley; David J Callans; Fermin Garcia; David Lin; Wendy Tzou; Rupa Bala; Francis E Marchlinski; Edward P Gerstenfeld
Journal:  Heart Rhythm       Date:  2011-01-12       Impact factor: 6.343

4.  Completion of mitral isthmus ablation using a steerable sheath: prospective randomized comparison with a nonsteerable sheath.

Authors:  Seiichiro Matsuo; Teiichi Yamane; Taro Date; Mika Hioki; Ryohsuke Narui; Keiichi Ito; Shin-Ichi Tanigawa; Tokiko Nakane; Seigo Yamashita; Michifumi Tokuda; Keiichi Inada; Ayumi Nojiri; Makoto Kawai; Ken-Ichi Sugimoto; Michihiro Yoshimura
Journal:  J Cardiovasc Electrophysiol       Date:  2011-06-07

5.  Balloon occlusion of the distal coronary sinus facilitates mitral isthmus ablation.

Authors:  Kelvin C K Wong; Michael Jones; Norman Qureshi; Praveen P Sadarmin; Joe De Bono; Kim Rajappan; Yaver Bashir; Timothy R Betts
Journal:  Heart Rhythm       Date:  2011-04-11       Impact factor: 6.343

6.  Arrhythmia type after persistent atrial fibrillation ablation predicts success of the repeat procedure.

Authors:  Sonia Ammar; Gabriele Hessling; Tilko Reents; Stephanie Fichtner; Jinjin Wu; Pinjun Zhu; Susanne Kathan; Heidi Louise Estner; Clemens Jilek; Christof Kolb; Bernhard Haller; Isabel Deisenhofer
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-08-19

7.  Impact of mitral isthmus anatomy on the likelihood of achieving linear block in patients undergoing catheter ablation of persistent atrial fibrillation.

Authors:  Miki Yokokawa; Baskaran Sundaram; Anubhav Garg; Jadranka Stojanovska; Hakan Oral; Fred Morady; Aman Chugh
Journal:  Heart Rhythm       Date:  2011-05-04       Impact factor: 6.343

8.  Comparison of voltage map-guided left atrial anterior wall ablation versus left lateral mitral isthmus ablation in patients with persistent atrial fibrillation.

Authors:  Hui-Nam Pak; Yong Seog Oh; Hong Euy Lim; Young-Hoon Kim; Chun Hwang
Journal:  Heart Rhythm       Date:  2010-10-13       Impact factor: 6.343

9.  Effect of mitral isthmus block on development of atrial tachycardia following ablation for atrial fibrillation.

Authors:  Ramtin Anousheh; Navinder S Sawhney; Michael Panutich; Charles Tate; Wei-Chung Chen; Gregory K Feld
Journal:  Pacing Clin Electrophysiol       Date:  2009-12-01       Impact factor: 1.976

10.  Ethanol infusion in the vein of Marshall: Adjunctive effects during ablation of atrial fibrillation.

Authors:  Miguel Valderrábano; Xiushi Liu; Christine Sasaridis; Jasvinder Sidhu; Stephen Little; Dirar S Khoury
Journal:  Heart Rhythm       Date:  2009-07-21       Impact factor: 6.343

View more
  31 in total

Review 1.  Ethanol for the treatment of cardiac arrhythmias.

Authors:  Paul Schurmann; Jorge Peñalver; Miguel Valderrábano
Journal:  Curr Opin Cardiol       Date:  2015-07       Impact factor: 2.161

2.  Electrogram characteristics of the coronary sinus in cases requiring epicardial ablation within the coronary sinus for creating a conduction block at the left lateral mitral isthmus.

Authors:  Daisuke Sato; Hiroki Mani; Yu Makihara; Hiroki Kitajima; Yuji Nishikawa; Seno Keitaro; Yeong-Hwa Chun
Journal:  J Interv Card Electrophysiol       Date:  2018-06-27       Impact factor: 1.900

3.  Ethanol infusion in the vein of Marshall leads to parasympathetic denervation of the human left atrium: implications for atrial fibrillation.

Authors:  José L Báez-Escudero; Takehiko Keida; Amish S Dave; Kaoru Okishige; Miguel Valderrábano
Journal:  J Am Coll Cardiol       Date:  2014-02-19       Impact factor: 24.094

4.  Recurrent perimitral flutter due to vein of Marshall epicardial connections bypassing the mitral isthmus: response to ethanol infusion.

Authors:  David F Briceño; Miguel Valderrábano
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-10

5.  Coronary venous ethanol infusion for the treatment of refractory ventricular tachycardia.

Authors:  Alex Baher; Dipan J Shah; Miguel Valderrabano
Journal:  Heart Rhythm       Date:  2012-06-06       Impact factor: 6.343

6.  Vein of Marshall ethanol infusion for persistent atrial fibrillation: VENUS and MARS clinical trial design.

Authors:  Miguel Valderrábano; Leif E Peterson; Raquel Bunge; Michelle Prystash; Amish S Dave; Sherif Nagueh; Neal S Kleiman
Journal:  Am Heart J       Date:  2019-05-11       Impact factor: 4.749

Review 7.  Atrial Fibrillation Ablation Using Vein of Marshall Ethanol Infusion.

Authors:  Adi Lador; Miguel Valderrábano
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-03-25

Review 8.  Ligament and vein of Marshall: A therapeutic opportunity in atrial fibrillation.

Authors:  Moisés Rodríguez-Mañero; Paul Schurmann; Miguel Valderrábano
Journal:  Heart Rhythm       Date:  2015-10-13       Impact factor: 6.343

9.  Ethanol Infusion in the Vein of Marshall in a Patient with Persistent Atrial Fibrillation.

Authors:  Jah Yeon Choi; Eun Jin Park; Hee Dong Kim; Sung Hun Park; Ji Young Song; Dae In Lee; Jaemin Shim; Young-Hoon Kim
Journal:  Korean Circ J       Date:  2015-06-30       Impact factor: 3.243

10.  Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial.

Authors:  Miguel Valderrábano; Leif E Peterson; Vijay Swarup; Paul A Schurmann; Akash Makkar; Rahul N Doshi; David DeLurgio; Charles A Athill; Kenneth A Ellenbogen; Andrea Natale; Jayanthi Koneru; Amish S Dave; Irakli Giorgberidze; Hamid Afshar; Michelle L Guthrie; Raquel Bunge; Carlos A Morillo; Neal S Kleiman
Journal:  JAMA       Date:  2020-10-27       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.